StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) shareholders

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)

Close on Nov 17, 2026Market cap $13.19MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
36.2%
3M of 8M shares
Institutional holders
36
4 new, 15 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
9 buys · 0 sales
Net bought $596.26K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Squadron Master Fund LP
Joint filing with Squadron Capital Management LLC (9.80%), Matthew Sesterhenn (9.80%) and 1 more
810,0009.80%13G (passive) amendmentJun 30, 2026
Matthew Sesterhenn
Joint filing with Squadron Master Fund LP (9.50%), Squadron Capital Management LLC (9.50%) and 1 more
530,0009.50%13G (passive) amendmentDec 31, 2025
Ikarian Capital, LLC
Joint filing with Neil Shahrestani (6.30%)
508,5566.30%13G (passive)Mar 31, 2026
Squadron Capital Management LLC
Joint filing with Squadron Master Fund LP (6.20%), Matthew Sesterhenn (6.20%) and 1 more
450,0006.20%13G (passive) amendmentMar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LPCNValueChange% of portfolio
Squadron Capital Management LLC810,0009.83%$2.07M+360,0000.64%
Ikarian Capital, LLC508,5566.17%$1.30M–0.14%
Eversept Partners, LP294,9893.58%$755.17K–0.04%
Vanguard Capital Management LLC230,8232.80%$590.91K+30,1550.00%
Acadian Asset Management LLC170,4172.07%$435.00KNew0.00%
Boothbay Fund Management, LLC140,4871.70%$359.65K–0.00%
Jane Street Group, LLC95,2271.16%$243.78K+75,2000.00%
BlackRock, Inc.89,2721.08%$228.54K–0.00%
Two Sigma Investments, LP84,8871.03%$217.31K+51,1370.00%
Citadel Advisors LLC81,2210.99%$207.93K+52,1330.00%
Seven Fleet Capital Management LP78,8420.96%$201.84K−46,1000.03%
Geode Capital Management, LLC74,4770.90%$190.76K+11,3420.00%
Renaissance Technologies LLC69,2090.84%$177.18K+30,7120.00%
Vanguard Fiduciary Trust Co54,5390.66%$139.62K+22,1260.00%
Dimensional Fund Advisors LP36,7750.45%$94.14K+17,6530.00%
Hrt Financial LP29,2380.35%$74.00KNew0.00%
Susquehanna International Group, Llp25,3760.31%$64.96K+4680.00%
State Street Corp22,4070.27%$57.36K–0.00%
Gsa Capital Partners Llp18,6660.23%$48.00KNew0.00%
Birchview Capital, LP16,7120.20%$42.78K−95,0740.02%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026363M36.2%4 / 143 / 151M1M
Q1 2026473M39.8%24 / 910 / 22M0M
Q4 2025262M19.8%8 / 72 / 41M0M
Q3 2025221M6.4%4 / 44 / 00M0M
Q2 2025181M6.4%1 / 56 / 20M0M
Q1 2025191M6.3%2 / 93 / 00M0M
Q4 2024170M5.9%1 / 45 / 20M0M
Q3 2024181M6.6%2 / 80 / 20M0M
Q2 2024191M6.4%4 / 65 / 30M0M
Q1 2024180M5.8%2 / 55 / 30M0M
Q4 2023190M5.9%1 / 74 / 30M0M
Q3 2023210M6.1%2 / 65 / 50M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

13 funds held LPCN in Q2 2026, 76% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of LPCNValue% of fundAs of
Vanguard Total Stock Market Index Fund142,7731.73%$365.50K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund57,8950.70%$148.21K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund29,7740.36%$66.99K0.00%May 31, 2026
Fidelity Total Market Index Fund8,6880.11%$19.55K0.00%May 31, 2026
Fidelity Series Total Market Index Fund8,2900.10%$18.65K0.00%May 31, 2026
Tiff Multi-Asset Fund6,2010.08%$15.87K0.00%Jun 30, 2026
U.S. Sustainability Core 1 Portfolio6,1810.07%$13.10K0.00%Jul 31, 2026
Dimensional U.S. Small Cap ETF6,0380.07%$12.80K0.00%Jul 31, 2026
Dimensional US Core Equity 1 ETF5,1160.06%$10.85K0.00%Jul 31, 2026
U.S. Micro Cap Portfolio5,0400.06%$10.68K0.00%Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF4,7600.06%$10.09K0.00%Jul 31, 2026
Fidelity Nasdaq Composite Index Fund4,4610.05%$10.04K0.00%May 31, 2026
Schwab Total Stock Market Index Fund2,9420.04%$6.24K0.00%Jul 31, 2026
U.S. Social Core Equity 2 Portfolio2,7300.03%$5.79K0.00%Jul 31, 2026
U.S. Vector Equity Portfolio2,1560.03%$4.57K0.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Mahesh V. PatelChief Executive Officer, Director400,2074.85%Nov 13, 2026
Krista FogartyPrincipal Accounting Officer1,7270.02%Dec 19, 2025
John W. HiguchiDirector299,8433.64%Oct 1, 2026
Michael GrissingerDirector––Aug 7, 2026
Jill M. JeneDirector––Jun 4, 2026
Richard Dana OnoDirector14,1250.17%Jun 4, 2026
Spyros PapapetropoulosDirector21,7390.26%Jun 5, 2025
Jeffrey Arvin FinkDirector6,5620.08%Jun 5, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mahesh V. Patel
Chief Executive Officer, Director
Nov 13, 2026Buy+25,000$1.60$40.00K211,495
Mahesh V. Patel
Chief Executive Officer, Director
Nov 12, 2026Buy+25,000$1.58$39.49K186,495
John W. Higuchi
Director
Sep 30, 2026Buy+15,970$2.23$35.61K241,365
John W. Higuchi
Director
Sep 29, 2026Buy+9,037$2.15$19.43K225,395
John W. Higuchi
Director
Sep 28, 2026Buy+12,561$2.16$27.13K216,358
John W. Higuchi
Director
Apr 7, 2026Buy+40,000$2.03$81.20K203,797
Mahesh V. Patel
Chief Executive Officer, Director
Apr 6, 2026Buy+25,000$2.03$50.75K160,679
John W. Higuchi
Director
Apr 6, 2026Buy+123,000$2.05$252.15K163,797
Mahesh V. Patel
Chief Executive Officer, Director
Apr 2, 2026Buy+25,000$2.02$50.50K135,679
Krista Fogarty
Principal Accounting Officer
Mar 8, 2024Award+991––1,727
Mahesh V. Patel
CEO and President, Director
Mar 8, 2024Award+4,893––112,311
Mahesh V. Patel
CEO and President, Director
May 25, 2023Buy+8,706$5.03$43.79K107,418
Mahesh V. Patel
CEO and President, Director
Mar 24, 2023Buy+150,000$0.32$48.00K1,678,090
Richard Dana Ono
Director
Mar 20, 2023Buy+4,000$0.34$1.36K14,125
Mahesh V. Patel
CEO and President, Director
Mar 17, 2023Buy+50,000$0.33$16.50K1,528,090
Spyros Papapetropoulos
Director
Nov 22, 2022Buy+21,739$0.47$10.22K21,739
Mahesh V. Patel
CEO and President, Director
Nov 14, 2022Buy+75,000$0.39$29.25K1,478,090
Mahesh V. Patel
CEO and President, Director
Sep 27, 2022Buy+100,000$0.41$41.00K1,403,090
Krista Fogarty
Principal Accounting Officer
May 17, 2022Buy+12,500$0.86$10.75K12,500
Mahesh V. Patel
CEO and President, Director
May 16, 2022Buy+50,000$0.77$38.50K1,303,090
Mahesh V. Patel
CEO and President, Director
Nov 18, 2021Buy+25,000$1.09$27.25K1,253,090
John W. Higuchi
Director
Dec 31, 2020Sale−1,700$1.35$2.30K698,548
John W. Higuchi
Director
Dec 31, 2020Sale−5,000$1.35$6.75K693,548
Stephen A. Hill
Director
Dec 16, 2020Option exercise+7,500––12,750
John W. Higuchi
Director
Dec 16, 2020Option exercise+3,750––700,248
Jeffrey Arvin Fink
Director
Dec 16, 2020Option exercise+5,625––6,562
Morgan R. Brown
EVP and CFO
Dec 16, 2020Sale(10b5-1 plan)−8,437$1.35$11.39K194,504
Morgan R. Brown
EVP and CFO
Dec 16, 2020Option exercise+28,125––202,941
Mahesh V. Patel
Chief Executive Officer, Director
Dec 16, 2020Option exercise+45,000––1,243,090
Mahesh V. Patel
Chief Executive Officer, Director
Dec 16, 2020Sale(10b5-1 plan)−15,000$1.35$20.25K1,228,090
Richard Dana Ono
Director
Dec 16, 2020Option exercise+5,250––10,125
Morgan R. Brown
Chief Financial Officer
Dec 5, 2020Option exercise+70,754––174,816
Mahesh V. Patel
Chief Executive Officer, Director
Dec 5, 2020Option exercise+122,978––1,198,090
Morgan R. Brown
Chief Financial Officer
Dec 4, 2020Sale(10b5-1 plan)−17,250$1.57$27.08K104,062
Morgan R. Brown
Chief Financial Officer
Dec 4, 2020Option exercise+57,500––121,312
Mahesh V. Patel
Chief Executive Officer, Director
Dec 4, 2020Sale(10b5-1 plan)−43,500$1.57$68.30K1,075,112
Mahesh V. Patel
Chief Executive Officer, Director
Dec 4, 2020Option exercise+145,000––1,118,612
John W. Higuchi
Director
Mar 17, 2020Buy+220,000$0.32$70.40K696,498
Mahesh V. Patel
CEO and President, Director
Dec 31, 2019Buy+40,000$0.38$15.20K973,612
Mahesh V. Patel
President and CEO, Director
Dec 10, 2019Buy+25,000$0.40$10.00K933,612
Morgan R. Brown
EVP and Chief Financial Office
Dec 4, 2019Sale(10b5-1 plan)−17,250$0.41$7.07K63,812
Morgan R. Brown
EVP and Chief Financial Office
Dec 4, 2019Option exercise+57,500––81,062
Mahesh V. Patel
CEO and President, Director
Dec 4, 2019Sale(10b5-1 plan)−43,500$0.41$17.84K908,612
Mahesh V. Patel
CEO and President, Director
Dec 4, 2019Option exercise+145,000––952,112
Mahesh V. Patel
President and CEO, Director
Nov 26, 2019Buy+21,928$0.43$9.43K807,112
Mahesh V. Patel
President and CEO, Director
Nov 26, 2019Buy+1,272$0.43$547783,384
Mahesh V. Patel
President and CEO, Director
Nov 26, 2019Buy+700$0.43$301784,084
Mahesh V. Patel
President and CEO, Director
Nov 26, 2019Buy+1,100$0.43$473785,184
Mahesh V. Patel
CEO and President, Director
Nov 18, 2019Buy+40,259$0.40$16.10K777,302
Mahesh V. Patel
CEO and President, Director
Nov 18, 2019Buy+4,810$0.42$2.02K782,112
Mahesh V. Patel
CEO and President, Director
Nov 18, 2019Buy+4,931$0.40$1.97K737,043
Mahesh V. Patel
President and CEO, Director
May 24, 2019Award+473$1.60$757729,612
Mahesh V. Patel
President and CEO, Director
May 24, 2019Award+2,500$1.64$4.10K732,112
Mahesh V. Patel
President and CEO, Director
May 24, 2019Award+4,527$1.58$7.15K726,639
Mahesh V. Patel
President and CEO, Director
May 24, 2019Award+2,500$1.59$3.98K729,139
Morgan R. Brown
EVP and CFO
Dec 29, 2017Option exercise+9,375––26,375
Morgan R. Brown
EVP and CFO
Dec 29, 2017Sale(10b5-1 plan)−2,813$3.47$9.76K23,562
Jeffrey Arvin Fink
Director
Dec 29, 2017Sale(10b5-1 plan)−938$3.47$3.25K937
Jeffrey Arvin Fink
Director
Dec 29, 2017Option exercise+1,875––1,875
Richard Dana Ono
Director
Dec 29, 2017Sale(10b5-1 plan)−875$3.47$3.04K4,875

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.34%
0M shares short
Days to cover
1.5
At 0M shares a day
Change since last report
-7.4%
From 0M shares
Short volume, 20 days
31.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lipocine's stock actually held short. Settlement fails (shares not delivered on time) peaked at 166,607 shares on Oct 8, 2026 over the last 90 days.

See a number that looks wrong?